Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check5 days agoChange DetectedTwo new sites were added to the study: Prairie Institute of Liver and Luminal Advanced Research in Bucharest, Romania (Site 0013) and Monza Ares SRL in Monza, Italy (Site 1604). The previous sites SIX08 Gastroenterology in Bucharest (Site 0013) and S.C. Centrul Medical Medicum SRL-Gastroenterology (Site 1604) were removed.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study's site list expanded to 476 locations, including Seattle (University of Washington Medical Center – Montlake), Santo André, Poznan, Pratia Poznan, and Nitra. The total locations increased from 472 to 476, dates were updated to 2025-12-02, 2026-08-01, and 2029-08-01, and extensive contact details were removed.SummaryDifference12%

- Check19 days agoChange DetectedRevision indicator updated: v3.3.2 added and v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision history updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange Detected- Removed the government funding status notice from the page. This does not change the study details, eligibility criteria, or the listed outcomes.SummaryDifference0.0%

- Check49 days agoChange DetectedReplaced the Colombia site location 'Santiago de Cali, Valle del Cauca Department, Colombia, 760032' with 'Cali, Valle del Cauca Department, Colombia, 760032' in the Locations list, and added the label 'Last Update Posted (Estimated)' to reflect update timing.SummaryDifference0.1%

Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.